Mhandire K, Saggu K, Buxbaum NP. Immunometabolic therapeutic targets of graft-versus-host disease (GvHD). Metabolites. 2021;11. https://doi.org/10.3390/metabo11110736.
Ciurea SO, Al Malki MM, Kongtim P, Zou J, Aung FM, Rondon G, et al. Treatment of allosensitized patients receiving allogeneic transplantation. Blood Adv. 2021;5:4031–43. https://doi.org/10.1182/bloodadvances.2021004862.
Article PubMed PubMed Central Google Scholar
Yoshihara S, Maruya E, Taniguchi K, Kaida K, Kato R, Inoue T, et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transpl. 2012;47:508–15. https://doi.org/10.1038/bmt.2011.131.
Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, et al. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transpl. 2018;53:521–34. https://doi.org/10.1038/s41409-017-0062-8.
Sicard A, Phares TW, Yu H, Fan R, Baldwin WM 3rd, Fairchild RL, et al. The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients. Am J Transpl. 2012;12:1708–19. https://doi.org/10.1111/j.1600-6143.2012.04009.x.
Richard C, Romón I, Perez-Encinas M, Baro J, Rabuñal MJ, Mazorra F, et al. Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemia. Leukemia. 1996;10:1615–8.
Orandi BJ, Lonze BE, Jackson A, Terezakis S, Kraus ES, Alachkar N, et al. Splenic irradiation for the treatment of severe antibody-mediated rejection. Am J Transpl. 2016;16:3041–5. https://doi.org/10.1111/ajt.13882.
Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transpl. 2006;38:291–7. https://doi.org/10.1038/sj.bmt.1705445.
Zhu L, Guo Z, Sa R, Guo H, Li J, Chen G. Case report: splenic irradiation for the treatment of chronic active antibody-mediated rejection in kidney allograft recipients with de novo donor-specific antibodies. Front Immunol. 2021;12:661614. https://doi.org/10.3389/fimmu.2021.661614.
Article PubMed PubMed Central Google Scholar
Yamamoto T, Watarai Y, Takeda A, Tsujita M, Hiramitsu T, Goto N, et al. De novo anti-HLA DSA characteristics and subclinical antibody-mediated kidney allograft injury. Transplantation. 2016;100:2194–202. https://doi.org/10.1097/tp.0000000000001012.
McManigle W, Youssef A, Sarantopoulos S. B cells in chronic graft-versus-host disease. Hum Immunol. 2019;80:393–9. https://doi.org/10.1016/j.humimm.2019.03.003.
Article PubMed PubMed Central Google Scholar
Weinmann M, Becker G, Einsele H, Bamberg M. Clinical indications and biological mechanisms of splenic irradiation in autoimmune diseases. Strahlenther Onkol. 2001;177:105–11. https://doi.org/10.1007/pl00002384.
留言 (0)